NEW YORK — The attorneys at Bernstein Liebhard LLP are now evaluating potential teething tablet lawsuits involving injuries and deaths that may be associated with the use of homeopathic teething pills and gels. On September 30th, the U.S. Food & Drug Administration (FDA) warned that these products may pose a risk to infants and children. It has since been revealed that homeopathic teething remedies have been implicated in more than 400 adverse event reports since 2010, including 10 infant deaths. While the FDA has not yet concluded that these teething tablets and pills were, in fact, responsible for the reported adverse events, the agency has cautioned against their use.
“Parents should be able to trust that the products they give to their children are safe and effective. The recent news surrounding homeopathic teething remedies is extremely disturbing,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is now offering free, no-obligation legal reviews to families whose children may have been harmed by homeopathic teething medications.
FDA Warning for Homeopathic Teething Tablets
According to the FDA, homeopathic teething tablets and gels are marketed by Hyland’s, Baby Orajel Naturals and others. Such products have not been evaluated or approved by the agency for safety or efficacy, and the FDA has said it is also not aware of any proven health benefit associated with these remedies. However, the agency is not issuing a teething tablet recall at this time.
Parents and caregivers who do use these products should seek medical attention if their child experiences:
- Difficulty breathing
- Excessive sleepiness
- Muscle weakness
- Skin flushing
- Difficulty urinating
Compensation may be available to the families of children who were allegedly harmed by homeopathic teething pills and gels.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal’s “Plaintiffs’ Hot List,” recognizing the top plaintiffs firms in the country. This year’s nomination marks the thirteenth year the firm has been named to this prestigious annual list. – PRNewswire